Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,446 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies.
Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, Kobayashi T, Yoshikawa T. Shimamoto C, et al. Among authors: yoshikawa t. Hum Mol Genet. 2015 Apr 15;24(8):2409. doi: 10.1093/hmg/ddv011. Epub 2015 Feb 5. Hum Mol Genet. 2015. PMID: 25655139 Free PMC article. No abstract available.
RTA-dh404 decreased oxidative stress in mice ischemic limbs and augmented efficacy of therapeutic angiogenesis by intramuscular injection of adipose-derived regenerative cells in the limbs.
Ishizaki Y, Sasaki KI, Yoshikawa T, Nakayoshi T, Sasaki M, Ohtsuka M, Hatada-Katakabe S, Takata Y, Fukumoto Y. Ishizaki Y, et al. Among authors: yoshikawa t. Eur J Pharmacol. 2022 Nov 25:175422. doi: 10.1016/j.ejphar.2022.175422. Online ahead of print. Eur J Pharmacol. 2022. PMID: 36442622
Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease.
Kawakami H, Nishikawa K, Shimokawa T, Fujitani K, Tamura S, Endo S, Kobayashi M, Kawada J, Kurokawa Y, Tsuburaya A, Yoshikawa T, Sakamoto J, Satoh T, On Behalf Of The Herbis-Herbis-A And XParTS Ii Study Investigators. Kawakami H, et al. Among authors: yoshikawa t. Cancers (Basel). 2022 Nov 18;14(22):5673. doi: 10.3390/cancers14225673. Cancers (Basel). 2022. PMID: 36428770 Free article.
4,446 results